196 related articles for article (PubMed ID: 35379158)
1. The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma Diagnosis.
Shi Y; Men J; Sun H; Tan J
Med Chem; 2022; 18(10):1073-1085. PubMed ID: 35379158
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
3. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
4. Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis.
Sun X; Ge X; Xu Z; Chen D
J Gastroenterol Hepatol; 2020 Jan; 35(1):157-164. PubMed ID: 31222831
[TBL] [Abstract][Full Text] [Related]
5. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
Chen S; Zhang Y; Ding X; Li W
Front Genet; 2022; 13():838869. PubMed ID: 35386284
[No Abstract] [Full Text] [Related]
6. Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis.
Yuan F; Tang Y; Cao M; Ren Y; Li Y; Yang G; Ou Q; Tustumi F; Levi Sandri GB; Raissi D; Pocha C; Deng M; Yao Z
Ann Transl Med; 2022 Jul; 10(14):769. PubMed ID: 35965793
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Pathogenic Biomarkers for Hepatocellular Carcinoma Based on RNA-seq Analyses.
Jiang W; Zhang L; Guo Q; Wang H; Ma M; Sun J; Chen C
Pathol Oncol Res; 2019 Jul; 25(3):1207-1213. PubMed ID: 30680535
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
9. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
10. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
11. [Identification of onco-miRNAs in hepatocellular carcinoma and analysis of their regulatory network].
Ye J; Xu W; Chen T
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):45-54. PubMed ID: 35249869
[TBL] [Abstract][Full Text] [Related]
12. Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
Deng R; Cui X; Dong Y; Tang Y; Tao X; Wang S; Wang J; Chen L
Front Genet; 2021; 12():626764. PubMed ID: 33719338
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion.
Chen W; Wang H; Li T; Liu T; Yang W; Jin A; Ding L; Zhang C; Pan B; Guo W; Wang B
BMC Med Genomics; 2022 Feb; 15(1):34. PubMed ID: 35197055
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel miRNA-based recurrence and prognosis prediction biomarker for hepatocellular carcinoma.
Zhang X; Zhang D; Bu X; Zhang X; Cui L
BMC Bioinformatics; 2022 Nov; 23(1):479. PubMed ID: 36376850
[TBL] [Abstract][Full Text] [Related]
15. Identification of serum exosomal miR-98-5p, miR-183-5p, miR-323-3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms.
Yang Q; Wei B; Peng C; Wang L; Li C
Curr Res Transl Med; 2022 Jan; 70(1):103315. PubMed ID: 34837760
[TBL] [Abstract][Full Text] [Related]
16. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
17. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
18. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
19. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
Song SK; Jung WY; Park SK; Chung CW; Park Y
PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595
[TBL] [Abstract][Full Text] [Related]
20. Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma.
Yerukala Sathipati S; Aimalla N; Tsai MJ; Carter T; Jeong S; Wen Z; Shukla SK; Sharma R; Ho SY
Carcinogenesis; 2023 Dec; 44(8-9):650-661. PubMed ID: 37701974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]